v3.23.1
Stock-Based Compensation - Schedule of Option and RSU Activity (Details)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Shares Available for Grant  
Balances at beginning of period (in shares) 108
Granted (in shares) (9)
Increase in shares available for grant (in shares) 32
Shares withheld for taxes (in shares) 1
Exercised/Vested (in shares) 0
Balances at end of period (in shares) 132
Number of Shares  
Balances at beginning of period (in shares) 22
Granted (in shares) 1
Increase in shares available for grant (in shares) 0
Shares withheld for taxes (in shares) 0
Exercised/Vested (in shares) (2)
Balances at end of period (in shares) 21
Weighted- Average Exercise Price  
Balances at beginning of period (in USD per share) | $ / shares $ 23.41
Granted (in USD per share) | $ / shares 122.41
Increase in shares available for grant (in USD per share) | $ / shares 0
Shares withheld for taxes (in USD per share) | $ / shares 0
Exercised/Vested (in USD per share) | $ / shares 10.75
Balances at end of period (in USD per share) | $ / shares $ 27.93
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Options outstanding (in shares) 21
Options exercisable (in shares) 18
Options outstanding (in USD per share) | $ / shares $ 27.93
Options excisable (in USD per share) | $ / shares $ 18.33
Options outstanding, weighted-average remaining contractual life (in years) 2 years 11 months 1 day
Options exercisable, weighted-average remaining contractual life (in years) 2 years 2 months 8 days
Options outstanding, aggregate intrinsic value | $ $ 2,053
Options exercisable, aggregate intrinsic value | $ $ 1,976
RSUs  
Number of Shares  
Balances at beginning of period (in shares) 34
Granted (in shares) 8
Increase in shares available for grant (in shares) 0
Shares withheld for taxes (in shares) (1)
Exercised/Vested (in shares) (3)
Balances at end of period (in shares) 38
Weighted- Average Grant Date Fair Value  
Balances at beginning of period (in USD per share) | $ / shares $ 77.07
Granted (in USD per share) | $ / shares 118.84
Increase in shares available for grant (in USD per share) | $ / shares 0
Shares withheld for taxes (in USD per share) | $ / shares 92.62
Exercised/Vested (in USD per share) | $ / shares 93.80
Balances at end of period (in USD per share) | $ / shares $ 84.33